A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Explore 11592 conditions in our directory, and growing.
Condition name for this article.

Eosinophilic granulomatosis with polyangiitis

Other Names: Churg-Strauss syndrome, Churg Strauss syndrome, Churg-Strauss disease, Churg Strauss disease, Churg-Strauss disorder, Churg Strauss disorder, Churg-Strauss vasculitis, Churg Strauss vasculitis, Churg-Strauss angiitis, Churg Strauss angiitis, Allergic granulomatosis, Allergic granulomatoses, Allergic angiitis, Allergic angiitides, Allergic granulomatosis and angiitis, Allergic granulomatoses and angiitides, Allergic angiitis and granulomatosis, Allergic angiitides and granulomatoses, Allergic granulomatous angiitis, Allergic granulomatous angiitides, Granulomatous allergic angiitis, Granulomatous allergic angiitides, Allergic granulomatosis angiitis, Allergic granulomatoses angiitides, Allergic granulomatous and angiitis.
Causes Symptoms Treatment Prognosis Lifestyle FAQ

At a Glance

Eosinophilic granulomatosis with polyangiitis is a rare autoimmune disease that causes inflammation in small and medium-sized blood vessels, resulting in restricted blood flow and potential damage to multiple organ systems, particularly the lungs and respiratory tract, nerves, and heart.
This rare condition typically develops in adults between the ages of 35 and 50, affecting men and women equally, though it can occasionally occur in other age groups.
It is a chronic, lifelong condition that cannot be cured, but it is treatable and manageable with long-term medication to control inflammation and maintain remission.
With early diagnosis and appropriate treatment, the majority of individuals achieve remission and have a good life expectancy, although the disease follows a relapsing course that requires ongoing medical monitoring.

See Your Ranked Personalized Treatments

A graphic depicting a sample medication report that registered members can run.
Impact in entire body.

How It Affects You

Eosinophilic granulomatosis with polyangiitis is a systemic condition where inflammation of the blood vessels, known as vasculitis, restricts blood flow and potentially damages organs and tissues throughout the body. While it almost always affects the respiratory system and lungs first, the accumulation of white blood cells called eosinophils can harm the nerves, skin, heart, kidneys, and digestive tract.
  • The condition frequently begins with severe, adult-onset asthma and sinus issues.
  • Nerve involvement may lead to tingling, numbness, or shooting pain in the hands and feet.
  • Inflammation can cause rashes on the skin or more serious damage to the heart muscle.
.

Causes and Risk Factors

Underlying Causes and Mechanisms
The exact cause of this condition remains unknown, but it is classified as an autoimmune disorder where the immune system mistakenly attacks healthy body tissues. The damage is primarily caused by two mechanisms: the accumulation of eosinophils (a specific type of white blood cell involved in allergic reactions) in tissues, and vasculitis, which is the inflammation of blood vessels. Researchers believe a combination of genetic susceptibility and environmental triggers plays a role in activating this immune response.

Risk Factors and Triggers
The most significant risk factor is a history of allergic conditions, specifically severe asthma and chronic sinusitis, which almost all patients experience before developing the full disease. Other potential triggers include respiratory infections or exposure to certain allergens that might stimulate the immune system excessively. While it runs in some families, it is not directly inherited in a simple pattern.

Prevention Strategies
Because the cause is unknown, there is no way to prevent the initial onset of the disease. Prevention efforts focus entirely on secondary prevention, which means taking prescribed medications to prevent flare-ups (relapses) and minimizing complications. Avoiding known allergic triggers and managing asthma effectively are standard parts of ongoing care.

A graphic depicting a sample medication report that registered members can run.
.

Diagnosis, Signs, and Symptoms

Phases of Symptoms
Symptoms typically develop in three phases, though they can overlap. The first is the allergic phase, characterized by adult-onset asthma and sinus problems like hay fever or nasal polyps. The second is the eosinophilic phase, where high levels of eosinophils accumulate in the blood and tissues, potentially causing fever, weight loss, and fatigue. The third is the vasculitic phase, where blood vessel inflammation causes specific organ damage.

Common Signs and Symptoms
Depending on which organs are affected, symptoms vary widely. Respiratory issues like coughing and shortness of breath are nearly universal. Neurological symptoms are very common and include numbness, tingling, or shooting pain in the hands and feet (peripheral neuropathy). Skin symptoms may appear as rashes, palpable purpura (purple spots), or nodules. Less commonly, patients may experience abdominal pain, diarrhea, or symptoms of heart failure if the heart is involved.

Diagnostic Tests
Clinicians use a combination of tests to confirm the diagnosis, as no single test is definitive. Blood tests reveal abnormally high eosinophil counts and markers of inflammation (like CRP or ESR). About half of patients test positive for specific antibodies called antineutrophil cytoplasmic antibodies (ANCA). Imaging scans, such as chest X-rays or CT scans, help identify lung abnormalities or sinus inflammation. A tissue biopsy is often the gold standard, where a small sample of an affected organ (like skin, nerve, or lung) is examined under a microscope to look for eosinophils and vasculitis.

Differential Diagnosis
Doctors must rule out other conditions that cause high eosinophils or vasculitis. These include severe persistent asthma, parasitic infections, fungal infections, and other forms of autoimmune vasculitis such as microscopic polyangiitis or granulomatosis with polyangiitis.

.

Treatment and Management

Medical Treatment Options
Treatment aims to suppress the immune system and reduce inflammation. High-dose corticosteroids, such as prednisone, are the standard first-line treatment to rapidly control symptoms. For more severe cases or to allow for tapering off steroids, doctors prescribe immunosuppressive drugs like cyclophosphamide, azathioprine, or methotrexate. Newer biologic therapies that specifically target eosinophils, such as mepolizumab, are also used to control the disease and reduce the need for steroids.

Management and Lifestyle
Long-term management involves monitoring for medication side effects, such as bone density loss or infection risk from immunosuppression. Patients are encouraged to maintain a heart-healthy diet, exercise regularly to counteract steroid side effects, and keep vaccinations up to date (non-live vaccines) to prevent infections. Quitting smoking is essential to protect lung health.

When to Seek Medical Care
Routine follow-up is necessary to monitor blood work and organ function. You should seek immediate medical attention if you experience difficulty breathing, chest pain, sudden weakness or loss of movement in a limb (foot drop or wrist drop), or severe abdominal pain. Worsening asthma symptoms or new rashes should prompt a call to your specialist.

A graphic depicting a sample medication report that registered members can run.
.

Severity and Prognosis

Severity and Complications
The severity of the condition ranges from mild forms restricted to the respiratory system to severe, life-threatening multi-organ disease. The most serious complications involve the heart (such as myocarditis) and the kidneys. Nerve damage (neuropathy) can be painful and disabling but is rarely fatal. Without treatment, the condition can be fatal due to organ failure, but modern therapies have drastically reduced this risk.

Disease Course and Prognosis
With treatment, the prognosis is generally good, and most people live a normal lifespan. However, the disease is chronic and characterized by periods of remission (no active disease) and relapse (return of symptoms). Relapses occur in a significant number of patients, often involving asthma or sinus issues. Long-term outcomes are influenced by how quickly treatment is started and whether major organs like the heart or gastrointestinal tract are involved.

Factors Influencing Outcomes
Clinicians often use a scoring system (Five-Factor Score) to assess prognosis based on age, kidney function, heart involvement, and gastrointestinal involvement. Early diagnosis significantly improves the chances of achieving remission without permanent organ damage.

.

Impact on Daily Life

Impact on Daily Activities
Fatigue is a common complaint, even when the disease is in remission, which can affect work and social activities. Peripheral neuropathy may make walking or using hands for fine tasks difficult, potentially requiring physical therapy or assistive devices. Managing chronic asthma may limit physical exertion for some individuals.

Mental and Emotional Health
Living with a chronic, relapsing rare disease can lead to anxiety and depression. The uncertainty of flare-ups and the side effects of corticosteroids, such as mood swings and changes in physical appearance, can impact self-esteem and emotional well-being. Support groups for vasculitis can provide valuable connection with others facing similar challenges.

Questions to Ask Your Healthcare Provider

  • What signs should I look for that indicate a relapse is starting?
  • How can I manage the side effects of long-term steroid use?
  • Are there specific vaccines I should get or avoid while on this treatment?
  • How often do I need blood tests or imaging to monitor my condition?
  • Is there a biologic medication that might be right for me?

A graphic depicting a sample medication report that registered members can run.
.

Common Questions and Answers

Q: Is Eosinophilic granulomatosis with polyangiitis contagious?
A: No, it is an autoimmune disease, not an infection, so it cannot be spread from person to person.

Q: Can this condition be cured?
A: There is currently no cure, but medications can put the disease into remission where there are no active symptoms for long periods.

Q: Is it hereditary?
A: It is not directly inherited like some genetic diseases, but genes may make a person more susceptible to developing it when exposed to certain environmental triggers.

Q: What is the main difference between this and regular asthma?
A: While both involve airway inflammation, this condition involves a systemic vasculitis with high eosinophils that can damage other organs like nerves, skin, and the heart, which regular asthma does not do.

Q: Does the condition go away on its own?
A: No, untreated disease can lead to severe organ damage and can be fatal; medical treatment is always required.

Content last updated on May 26, 2026. Always consult a qualified health professional before making any treatment decisions or taking any medications. Review our Terms of Service for full details.